ArticleCancers2021

PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy.

Beatriz Grandal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.